venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $281,884 (100.0% shares, 0.0% debt)

Holdings (5)

ALXO ALX ONCOLOGY HLDGS INC 38.4%

Value ($000) $108,154 Shares 9,699,925 Est. Cost $39.31 Unrealized -64.3%

PHVS PHARVARIS N V 35.2%

Value ($000) $99,126 Shares 4,289,304 Est. Cost $21.15 Unrealized +25.6%

HRMY HARMONY BIOSCIENCES HLDGS IN 12.3%

Value ($000) $34,769 Shares 1,035,396 Est. Cost $36.46 Unrealized -12.0%

— ACELYRIN INC 9.2%

Value ($000) $26,004 Shares 3,852,470 Est. Cost $20.90 Unrealized —

— ELEVATION ONCOLOGY INC 4.9%

Value ($000) $13,831 Shares 2,696,133 Est. Cost $9.24 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$108,154	38.4%	$39.31	-64.3%	COM	00166B105
PHVS	PHARVARIS N V	4,289,304	$99,126	35.2%	$21.15	+25.6%	COM	N69605108
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,035,396	$34,769	12.3%	$36.46	-12.0%	COM	413197104
—	ACELYRIN INC	3,852,470	$26,004	9.2%	$20.90	—	COM	00445A100
—	ELEVATION ONCOLOGY INC	2,696,133	$13,831	4.9%	$9.24	—	COM	28623U101